Effect of 5-α dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse

Proceedings of the Society for Experimental Biology and Medicine

Volumn 213, Issue 3, 1996, Pages 287-293

  Toyoda, Hiroo ^a,c   Takei, Shinichiro ^a   Formby, Bent ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; FEMALE; HELPER CELL; HORMONE ACTION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED NOD; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; T-LYMPHOCYTES; TH2 CELLS;

ANIMALIA;

EID: 0030480809     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Costano L, Eisenbarth GS. Type 1 diabetes: A chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647-679, 1990.
2. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285-322, 1992.
3. Rotter JI, Vadheim CM, Rimoin DL. 1992. Diabetes mellitus. In: King RA, Rotter JI, Motulsky AG, Eds. The Genetic Basis of Common Diseases. New York: Oxford University Press, p 413, 1992.
4. Birk O, Cohen IR, T-cell autoimmunity in type I diabetes mellitus. Curr Opin Immunol 5:903-909, 1993.
5. Toyoda H, Formby B, Magalong D, Redford A, Chan E, Takei S, Charles MA. In situ islet cytokine gene expression during development of type I diabetes in the nonobese diabetic mouse. Immunol Lett 32:241-246, 1994.
6. Toyoda H, Redford A, Magalong D, Chan E, Hoszufalusi N. Formby B, Teruya M, Charles MA. In situ T-cell receptor variable region gene usage in the nonobese diabetic mouse. Immunol Lett 32:241-246, 1992.
7. Ansar Ahmed S, Penhale WJ, Talal N. 1985. Sex hormones, immune responses, and autoimmune diseases. Am J Pathol 121:531-551, 1985.
8. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 40:619-637, 1991.
9. Hawkins T, Gala RR, Dunbar JC. The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proc Soc Exp Biol Med 202:201-205, 1993.
10. Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 175:1409-1412, 1992.
11. Serreze DV, Leiter EH. 1988. Defective activation of T suppressor cell function in nonobese diabetic mice: Potential relation to cytokine deficiences. J Immunol 140:3801-3807, 1988.
12. Formby B, Miller N. Autologous CD4 T-cell response to ectopic class II major histocompatibility complex antigen-expressing single-cell islet T-cells: An in vivo insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. Proc Natl Acad Sci USA 87:2438-2442, 1990.
13. Formby B, Hoffzufalusi N. Chan E, Miller N. Teruya M, Takei S, Charles MA. Quantitative and functional analyses of spleen and in situ islet immune cells before and after diabetes onset in the NOD mouse. Autoimmunity 12:95-102, 1992.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
15. Andus T, Targan SR, Deem R, Toyoda H. Measurement of tumor necrosis factor and mRNA in small numbers of cells by quantitative polymerase chain reaction. Reg Immunol 5:11-17, 1993.
16. Montgomery RA, Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 147:554-560, 1991.
17. Mossmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989.
18. Luqman M, Johnson P, Trowbridge I, Bottomly K. Differential expression of the alternatively spliced exons of murine CD45 in Th1 and Th2 cell clones. Eur J Immunol 21:17-22, 1991.
19. Birkeland ML, Johnson P, Trowbridge IS, Pure E. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc Natl Acad Sci USA 86:6734-6738, 1989.
20. + murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset. J Exp Med 171:2171-2176, 1990.
21. McKean DJ, Podzorski RP, Bell MP, Nilson AE, Huntoon CJ, Slack J, Dower SK, Sims J. Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity. J Immunol 151:3500-3510, 1993.
22. Lichtman AH, Chin J, Schmidt JA, Abbas AK. Role of interleukin 1 in the activation of lymphocytes. Proc Natl Acad Sci USA 85:9699-9703, 1988.
23. + T cells for Plasmodium chabaudi. Immunology 81:216-221, 1994.
24. Zubiaga AM, Munoz E, Huber BT. Production of IL-1α by activated Th type 2 cells: Its role as an autocrine growth factor. J Immunol 146:3849-3856, 1991.
25. Manetti R, Barak V, Piccinni MP, Sampognaro S, Parronchi P, Maggi E, Dinarello CA, Romagnani S. Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clone. Res Immunol 145:93-100, 1994.
26. Formby B, Jacob C, Dubue P, Shao T. Exogenous administration of IL-1α inhibits active and adoptive transfer autoimmune diabetes in NOD mice. Autoimmunity 12:21-27, 1992.
27. Sakane T, Steinberg AD, Green I. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 75:3454-3468, 1978.
28. Hafler DA, Chofflon M, Kurt-Jones E, Weiner HL. Interleukin-1 corrects the defective autologous mixed lymphocyte response in multiple sclerosis. Clin Immunol Immunopathol 58:115-125, 1991.
29. Akasu F, Poplonski L, Snow KM, Volpe R, Keystone EC. Impaired generation of high-affinity interleukin-2 receptors in the autologous mixed lymphocyte reaction in rheumatoid arthritis. Clin Immunol Immunopathol 63:142-147, 1992.
30. Toplies D, How J, Lewis M, Row V, Volpe R. Evidence for cell-mediated immunity and specific suppressor T-lymphocyte dysfunction in Grave's disease and diabetes mellitus. J Clin Endocrinol Metab 57:700-705, 1983.
31. Glimcher LH, Steinberg AD, House SB, Green I. The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J Immuol 125:1832-1838, 1980.
32. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543, 1993.
33. Zanderer M. Origin and significance of autoreactive T cells. Adv Immunol 145:417-437, 1989.
34. Katz JD, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089-1100, 1993.
35. Gulshan SA, McCruden B, Stimson WH. Oestrogen receptors in macrophages. Scand J Immunol 31:691-697, 1990.
36. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-γ promoter. J Immunol 146:4362-4367, 1991.
37. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and γ-interferon, but not IL-2 by activated murine T-cells. Blood 78:3688-3699, 1991.